Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SKLB-BiCAR01
- Development stage
- Unknown
- Lead developer
- Nanjing Sanhome Pharmaceutical
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
- Administration
- Intravenous
01
Overview
SKLB-BiCAR01 is an autologous, dual-targeting chimeric antigen receptor (CAR) T-cell therapy developed by the State Key Laboratory of Biotherapy at Sichuan University and West China Hospital. The therapy is engineered to simultaneously target B-cell maturation antigen (BCMA) and CD19, two proteins highly expressed on the surface of malignant plasma cells in multiple myeloma. By utilizing a bispecific CAR construct, SKLB-BiCAR01 aims to enhance therapeutic efficacy and mitigate the risk of disease relapse caused by antigen escape, which is a significant challenge for single-target CAR-T therapies. It is currently undergoing Phase I/II clinical evaluation for patients with relapsed or refractory multiple myeloma.
- Other names
- SKLB-BiCAR01SKLB-BiCAR-01SKLB-BiCAR 01
Beyond the preview
Go deeper on SKLB-BiCAR01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SKLB-BiCAR01.